Clinical Trial Update: Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children [Phase 3]

View source ↗

Summary

Phase 3 results assess efficacy, safety, and immunogenicity of Takeda's tetravalent dengue vaccine (TDV) in healthy children, with results posted after trial co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue Fever

Drugs mentioned

• Tetravalent Dengue Vaccine (TDV) (tetravalent dengue vaccine)

Snippet

Sponsor: Takeda | Conditions: Healthy Volunteers | Phase 3 | Status: COMPLETED | Results posted: 2021-08-18